Clinical trials
Phase 3 Hepatitis C trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
247 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 11 |
| 2003 | 6 |
| 2004 | 5 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 8 |
| 2008 | 6 |
| 2009 | 4 |
| 2010 | 5 |
| 2011 | 20 |
| 2012 | 29 |
| 2013 | 23 |
| 2014 | 30 |
| 2015 | 32 |
| 2016 | 22 |
| 2017 | 18 |
| 2018 | 6 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 206 |
| Unknown status | 17 |
| Terminated | 16 |
| Withdrawn | 7 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 40 |
| Gilead Sciences | 35 |
| Bristol-Myers Squibb | 26 |
| Merck Sharp & Dohme LLC | 10 |
| Janssen R&D Ireland | 7 |
| AbbVie (prior sponsor, Abbott) | 6 |
| Boehringer Ingelheim | 4 |
| Debiopharm International SA | 4 |
| French National Agency for Research on AIDS and Viral Hepatitis | 4 |
| GlaxoSmithKline | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis C | 247 |
| Hepatitis C, Chronic | 82 |
| Fibrosis | 25 |
| Hepatitis | 13 |
| Liver Diseases | 12 |
| Virus Diseases | 11 |
| Liver Cirrhosis | 10 |
| HIV Infections | 9 |
| Acquired Immunodeficiency Syndrome | 8 |
| Hepatitis, Chronic | 6 |
Trials
Showing 76 to 100 of 247. Each trial links to its page on Pharma Observatory.
147 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.